Press release
Paris, May 19, 2021
COMBINED ORDINARY AND EXTRAORDINARY
SHAREHOLDERS' MEETING
MAY 6, 2021
Number of shareholders present or reprensented to the meeting : | 372 |
Number of shareholder shares present or represented to the meeting : | 18,042,479 |
Number of shareholder votes present or reprensented to the meeting : | 22,256,952 |
GENERAL QUORUM reached
Votes cast | Exclusions | For | Against | Forbearance | ||||||||||
(in number and | (in number | (in number | (in number and | (in number and | ||||||||||
and | and | |||||||||||||
proportion | proportion | proportion | ||||||||||||
Resolutions | Result | proportion | proportion | |||||||||||
of votes | of votes | of votes | of votes | of votes | ||||||||||
cast) | cast) | cast) | cast) | cast) | ||||||||||
RESOLUTIONS SUBMITTED TO ORDINARY SHAREHOLDERS' MEETING | ||||||||||||||
Review and approval of the | 17,104 | |||||||||||||
1. | statutory financial statements for | Adopted | 22,256,952 | - | 22,239,308 | 540 | ||||||||
the fiscal year ended November | ||||||||||||||
30, 2020 | ||||||||||||||
83.10% | 99.998% | 0.002% | 0.077% | |||||||||||
Appropriation of earnings for the | 22,256,952 | - | 22,215,275 | 41,540 | 37 | |||||||||
2. | fiscal year ended November 30, | |||||||||||||
Adopted | ||||||||||||||
2020 | 83.10% | 99.81% | 0.19% | 0.00% | ||||||||||
Examination and approval of the | - | 22,239,308 | 540 | 17,104 | ||||||||||
3. | consolidated financial statements | Adopted | 22,256,952 | |||||||||||
for the fiscal year ended | ||||||||||||||
November 30, 2020 | ||||||||||||||
83.10% | 99.998% | 0.002% | 0.077% | |||||||||||
Review and approval of | 22,256,952 | - | 22,224,110 | 540 | 37 | |||||||||
4. | agreements referred to in Article L. | |||||||||||||
Adopted | ||||||||||||||
225-38 of the Commercial Code | ||||||||||||||
83.10% | 100.00% | 0.00% | 0.00% | |||||||||||
Approval of the compensation | 22,206,452 | 50,000 | 22,046,453 | 159,045 | 1,454 | |||||||||
5. | policy for the Chairman and Chief | |||||||||||||
Adopted | ||||||||||||||
Executive Officer | ||||||||||||||
82.86% | 0.23% | 99.28% | 0.72% | 0.01% | ||||||||||
6. | Approval of the remuneration | Adopted | 22,256,452 | 500 | 22,198,640 | 57,219 | 593 | |||||||
policy for directors | ||||||||||||||
83.09% | 0.00% | 99.74% | 0.26% | 0.00% |
Votes cast | For | Against | Forbearance | ||||||||||||
(in number and | (in number | (in number and | (in number and | ||||||||||||
and | |||||||||||||||
proportion | proportion | proportion | |||||||||||||
Resolutions | Result | proportion | |||||||||||||
of votes | of votes | of votes | of votes | ||||||||||||
cast) | cast) | cast) | cast) | ||||||||||||
Approval of fixed, variable and | |||||||||||||||
exceptional items making up the | |||||||||||||||
total compensation and benefits of | 22,206,952 | 50,000 | 20,900,426 | 1,217,348 | 89,180 | ||||||||||
7. | any kind paid during the fiscal year | Adopted | |||||||||||||
ended November 30, 2020 or | |||||||||||||||
allocated for the same fiscal year | |||||||||||||||
to the Chairman - Chief Executive | |||||||||||||||
Officer | |||||||||||||||
82.86% | 0.00% | 94.50% | 5.50% | 0.40% | |||||||||||
Approval of the information | 22,256,952 | - | 22,224,087 | 32,828 | 37 | ||||||||||
8. | mentioned in Article L.22-10-9-I of | ||||||||||||||
Adopted | |||||||||||||||
the Commercial Code | |||||||||||||||
83.10.% | 99.85% | 0.15% | 0.00% | ||||||||||||
Recognition of the expiration of the | |||||||||||||||
term of office of Mr. Nordine | 22,256,952 | - | 20,998,776 | 1,588,139 | 37 | ||||||||||
9. | HACHEMI, renewal of the term of | ||||||||||||||
Adopted | |||||||||||||||
office of Mr. Nordine HACHEMI for | |||||||||||||||
a period of three years | |||||||||||||||
83.10% | 92.87% | 7.14% | 0.00% | ||||||||||||
Recognition of the expiration of the | 22,256,952 | - | 22,170,970 | 85,880 | 102 | ||||||||||
10. | director mandate of Mr. André | Adopted | |||||||||||||
MARTINEZ, appointment of a new | |||||||||||||||
director for a period of three years | |||||||||||||||
83.10% | 99.61% | 0.37% | 0.00% | ||||||||||||
Recognition of the expiration of the | |||||||||||||||
term of office of Mrs. Sylvie | 22,256,952 | - | 22,181,760 | 75,155 | 37 | ||||||||||
11. | CHARLES, renewal of the term of | ||||||||||||||
Adopted | |||||||||||||||
office of Mrs. Sylvie CHARLES for a | |||||||||||||||
period of three years | |||||||||||||||
83.10% | 99.66% | 0.34% | 0.00% | ||||||||||||
Recognition of the expiration of the | |||||||||||||||
term of office of Mrs. Sophie | 22,256,952 | - | 21,990,057 | 266,858 | 37 | ||||||||||
12. | LOMBARD, renewal of the term of | Adopted | |||||||||||||
office of Mrs. Sophie LOMBARD for | |||||||||||||||
a period of three years | |||||||||||||||
83.10% | 98.80% | 1.20% | 0.00% | ||||||||||||
Recognition of the expiration of the | |||||||||||||||
term of office of Mrs. Lucile RIBOT, | |||||||||||||||
13. | renewal of the term of office of | Adopted | 22,256,952 | - | 22,238,216 | 18,699 | 37 | ||||||||
Mrs. Lucile RIBOT for a period of | |||||||||||||||
three years | |||||||||||||||
83.10% | 99.92% | 0.08% | 0.00% | ||||||||||||
Recognition of the expiration of the | |||||||||||||||
mandate of director representing | |||||||||||||||
14. | the employee shareholders of Mrs. | Adopted | 22,256,952 | - | 22,237,292 | 18,699 | 1,051 | ||||||||
Karine NORMAND, renewal of the | |||||||||||||||
mandate of director of Mrs. Karine | |||||||||||||||
2/5 | |||||||||||||||
COMBINED ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING | |||||||||||||||
MAY 6, 2021 | |||||||||||||||
Votes cast | For | Against | Forbearance | |||||||||||||||||||||||
(in number and | (in number | (in number and | (in number and | |||||||||||||||||||||||
and | ||||||||||||||||||||||||||
proportion | proportion | proportion | ||||||||||||||||||||||||
Resolutions | Result | proportion | ||||||||||||||||||||||||
of votes | of votes | of votes | of votes | |||||||||||||||||||||||
cast) | cast) | cast) | cast) | |||||||||||||||||||||||
NORMAND for a period of three | 83.10% | 99.92% | 0.08% | 0.00% | ||||||||||||||||||||||
years | ||||||||||||||||||||||||||
Recognition of the expiration of the | ||||||||||||||||||||||||||
term of office as director of Mrs. | 22,256,952 | - | 22,140,078 | 116,837 | 37 | |||||||||||||||||||||
15. | Caroline PUECHOULTRES, | |||||||||||||||||||||||||
Adopted | ||||||||||||||||||||||||||
appointment of a new director for | ||||||||||||||||||||||||||
a period of three years | ||||||||||||||||||||||||||
83.10% | 99.48% | 0.53% | 0.00% | |||||||||||||||||||||||
Recognition of the expiration of the | ||||||||||||||||||||||||||
terms of office of ERNST & YOUNG | ||||||||||||||||||||||||||
AUDIT, statutory auditor of the | 22,256,952 | - | 20,107,516 | 2,149,399 | 37 | |||||||||||||||||||||
16. | Company and of AUDITEX, deputy | Adopted | ||||||||||||||||||||||||
auditor of the Company; | ||||||||||||||||||||||||||
appointment of statutory auditors | ||||||||||||||||||||||||||
for a period of six fiscal years | ||||||||||||||||||||||||||
83.10% | 90.34% | 9.66% | 0.00% | |||||||||||||||||||||||
Recognition of the expiration of the | 22,256,952 | - | 22,244,175 | 12,740 | 37 | |||||||||||||||||||||
mandates of DELOITTE & ASSOCIES, | ||||||||||||||||||||||||||
statutory auditor of the Company | ||||||||||||||||||||||||||
17. | and of B.E.A.S., deputy auditor of | Adopted | 83.10% | 99.94% | 0.06% | 0.00% | ||||||||||||||||||||
the Company; appointment of | ||||||||||||||||||||||||||
statutory auditors for a period of six | ||||||||||||||||||||||||||
fiscal years | ||||||||||||||||||||||||||
Authorization to be granted to the | 22,256,952 | - | 22,205,810 | 20,661 | 30,481 | |||||||||||||||||||||
board of directors, for a period of | ||||||||||||||||||||||||||
18. | eighteen months, for the purpose | Adopted | 83.10% | 99.91% | 0.09% | 0,14% | ||||||||||||||||||||
of purchasing by the company its | ||||||||||||||||||||||||||
own shares | ||||||||||||||||||||||||||
31. | Powers for completing formalities | Adopted | 22,256,952 | - | 22,256,377 | 540 | 35 | |||||||||||||||||||
83.10% | 100.00% | 0.00% | 0.00% | |||||||||||||||||||||||
RESOLUTIONS SUBMITTED TO EXTRAORDINARY SHAREHOLDERS' MEETING | ||||||||||||||||||||||||||
Authorization to be granted to the board | ||||||||||||||||||||||||||
19. | of directors, for a period of twenty-six | 22 256 952 | - | 22,255,296 | 1,619 | 37 | ||||||||||||||||||||
months, for the purpose of canceling | Adopted | |||||||||||||||||||||||||
shares held by the Company following | ||||||||||||||||||||||||||
the repurchase of its own shares | 83,10% | 10.00% | 0.00% | 0.00% | ||||||||||||||||||||||
Delegation of authority to be granted to | ||||||||||||||||||||||||||
20. | the board of directors, for a period of | 22 256 952 | - | 22,256,375 | 540 | 37 | ||||||||||||||||||||
twenty-six months, for the purpose of | Adopted | |||||||||||||||||||||||||
increasing the share capital by | 83,10% | 100.00% | 0.00% | 0.00% | ||||||||||||||||||||||
incorporation of reserves or premiums | ||||||||||||||||||||||||||
Delegation of authority to be granted to | ||||||||||||||||||||||||||
the board of directors, for a period of | ||||||||||||||||||||||||||
twenty-six months, for the purpose of | 22 256 952 | - | 21,171,112 | 85,803 | 37 | |||||||||||||||||||||
issuing ordinary shares and / or equity | ||||||||||||||||||||||||||
securities giving access to other equity | ||||||||||||||||||||||||||
21. | securities or giving the right to the | Adopted | ||||||||||||||||||||||||
allocation of debt securities and / or | ||||||||||||||||||||||||||
marketable securities giving access to | ||||||||||||||||||||||||||
equity securities to be issued by the | 83,10% | 9.61% | 0.39% | 0.00% | ||||||||||||||||||||||
Company with maintenance of | ||||||||||||||||||||||||||
shareholders' preferential subscription | ||||||||||||||||||||||||||
rights | ||||||||||||||||||||||||||
Delegation of authority to be granted to | ||||||||||||||||||||||||||
the board of directors, for a period of | ||||||||||||||||||||||||||
twenty-six months, for the purpose of | 22 256 952 | - | 21,603,813 | 653,813 | 37 | |||||||||||||||||||||
issuing ordinary shares and / or equity | ||||||||||||||||||||||||||
22. | ||||||||||||||||||||||||||
securities giving access to other equity | Adopted | |||||||||||||||||||||||||
securities or giving the right to the | ||||||||||||||||||||||||||
allocation of debt securities and / or | 83,10% | 97.06% | 2.94% | 0.00% | ||||||||||||||||||||||
marketable securities giving access to | ||||||||||||||||||||||||||
equity securities to be issued by the | ||||||||||||||||||||||||||
3/5 | ||||||||||||||||||||||||||
COMBINED ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING | ||||||||||||||||||||||||||
MAY 6, 2021 | ||||||||||||||||||||||||||
Votes cast | For | Against | Forbearance | ||||||||||||||||
(in number and | (in number | (in number and | (in number and | ||||||||||||||||
and | |||||||||||||||||||
proportion | proportion | proportion | |||||||||||||||||
Resolutions | Result | proportion | |||||||||||||||||
of votes | of votes | of votes | of votes | ||||||||||||||||
cast) | cast) | cast) | cast) | ||||||||||||||||
Company, with cancellation of | |||||||||||||||||||
shareholders' preferential subscription | |||||||||||||||||||
rights, within the framework of public | |||||||||||||||||||
offers other than those referred to in l | |||||||||||||||||||
Article L.411-2 of the Monetary and | |||||||||||||||||||
Financial Code | |||||||||||||||||||
Delegation of authority to be granted to | |||||||||||||||||||
the board of directors, for a period of | |||||||||||||||||||
twenty-six months, for the purpose of | 22 256 952 | 21,098,191 | 1,158,724 | 37 | |||||||||||||||
issuing ordinary shares, and / or equity | |||||||||||||||||||
securities giving access to other equity | |||||||||||||||||||
securities or giving rights to the allocation | |||||||||||||||||||
23. | of debt securities, and / or marketable | Adopted | |||||||||||||||||
securities giving access to equity | |||||||||||||||||||
securities to be issued by the Company, | |||||||||||||||||||
with cancellation of shareholders' | 83,10% | 94.80% | 5.21% | 0.00% | |||||||||||||||
preferential subscription rights, within the | |||||||||||||||||||
framework of public offers referred to in 1 | |||||||||||||||||||
of Article L.411-2 of the Monetary and | |||||||||||||||||||
Financial Code | |||||||||||||||||||
Authorization to be granted to the board | |||||||||||||||||||
of directors, for a period of twenty-six | |||||||||||||||||||
months, in the event of the issue of | |||||||||||||||||||
ordinary shares, and / or equity securities | 22 256 952 | - | 21,052,836 | 1,204,079 | 37 | ||||||||||||||
giving access to other equity securities or | |||||||||||||||||||
24. | giving right to the allocation of debt | ||||||||||||||||||
securities, and / or marketable securities | Adopted | ||||||||||||||||||
giving access to equity securities to be | |||||||||||||||||||
issued by the Company with cancellation | |||||||||||||||||||
of shareholders' preferential subscription | |||||||||||||||||||
rights, to set the issue price according to | 83,10% | 94.60% | 5.41% | 0.00% | |||||||||||||||
the terms set by the general meeting | |||||||||||||||||||
within the limit of 10% of the share capital | |||||||||||||||||||
Authorization to be granted to the board | |||||||||||||||||||
of directors, for a period of twenty-six | |||||||||||||||||||
25. | months, in order to increase the number | 22 256 952 | - | 21,044,163 | 1,212,752 | 37 | |||||||||||||
of securities to be issued in the event of a | Adopted | ||||||||||||||||||
capital increase with maintenance or | |||||||||||||||||||
with elimination of shareholders' | |||||||||||||||||||
preferential subscription rights | |||||||||||||||||||
83,10% | 94.45% | 5.45% | 0.00% | ||||||||||||||||
Delegation of authority to be granted to | |||||||||||||||||||
the board of directors, for a period of | |||||||||||||||||||
twenty-six months, for the purpose of | |||||||||||||||||||
issuing shares or equity securities giving | |||||||||||||||||||
26. | access to other equity securities or giving | Adopted | 22 256 952 | - | 22,131,859 | 123,066 | 37 | ||||||||||||
the right to the allocation debt securities | |||||||||||||||||||
as remuneration for contributions in kind | |||||||||||||||||||
of equity securities or marketable | |||||||||||||||||||
securities giving access to the capital | |||||||||||||||||||
within the limit of 10% of the share capital | 83,10% | 99.44% | 0.56% | 0.00% | |||||||||||||||
Delegation of authority to be granted to | |||||||||||||||||||
the board of directors, for a period of | |||||||||||||||||||
twenty-six months, for the purpose of | |||||||||||||||||||
27. | issuing shares and / or equity securities | 22 256 952 | - | 14,168,813 | 8,088,102 | 37 | |||||||||||||
giving access to other equity securities or | rejected | ||||||||||||||||||
to the allocation debt securities as | |||||||||||||||||||
remuneration for securities contributed to | |||||||||||||||||||
any public exchange offer initiated by | |||||||||||||||||||
the Company | 83,10% | 63.66% | 36.34% | 0.00% | |||||||||||||||
Delegation of authority to be granted to | |||||||||||||||||||
the board of directors, for a period of | |||||||||||||||||||
28. | twenty-six months, for the purpose of | Adopted | 22 256 952 | - | 22,131,871 | 125,044 | 37 | ||||||||||||
issuing shares and / or securities giving | |||||||||||||||||||
access to the Company's shares to be | |||||||||||||||||||
issued with cancellation of the | |||||||||||||||||||
4/5
COMBINED ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING
MAY 6, 2021
Votes cast | For | Against | Forbearance | ||||||||||||||||||
(in number and | (in number | (in number and | (in number and | ||||||||||||||||||
and | |||||||||||||||||||||
proportion | proportion | proportion | |||||||||||||||||||
Resolutions | Result | proportion | |||||||||||||||||||
of votes | of votes | of votes | of votes | ||||||||||||||||||
cast) | cast) | cast) | cast) | ||||||||||||||||||
preferential subscription right of | |||||||||||||||||||||
shareholders, for the benefit of members | 83,10% | 99.44% | 0.56% | 0.00% | |||||||||||||||||
of the group's Company Savings Plan (s) | |||||||||||||||||||||
for an amount of 3% of the capital | |||||||||||||||||||||
Authorization to be granted to the board | |||||||||||||||||||||
of directors, for a period of thirty-eight | |||||||||||||||||||||
29. | months, for the purpose of allocating free | 22 256 952 | - | 21,589,949 | 579,240 | 87,763 | |||||||||||||||
shares to be issued or existing for the | Adopted | ||||||||||||||||||||
benefit of employees and / or executive | |||||||||||||||||||||
corporate officers of the Company and | |||||||||||||||||||||
related entities | |||||||||||||||||||||
83,10% | 97.39% | 2.61% | 0.39% | ||||||||||||||||||
Setting of the general ceilings for | |||||||||||||||||||||
delegations of authority at a nominal | |||||||||||||||||||||
amount of (i) € 2,270,000 for all capital | |||||||||||||||||||||
increases through the issue of shares or | 22 256 952 | 22,129,522 | 127,393 | 37 | |||||||||||||||||
equity securities giving access to other | |||||||||||||||||||||
equity securities or securities giving | |||||||||||||||||||||
access to equity securities to be issued, | |||||||||||||||||||||
(ii) € 568,000 for capital increases through | |||||||||||||||||||||
30. | the issue of shares or equity securities | ||||||||||||||||||||
giving access to other equity securities or | Adopted | ||||||||||||||||||||
securities securities giving access to | |||||||||||||||||||||
equity securities to be issued with | |||||||||||||||||||||
cancellation of preferential subscription | 83,10% | - | 99.43% | 0.57% | 0.00% | ||||||||||||||||
rights and (iii) € 500,000,000, for issues of | |||||||||||||||||||||
debt securities giving the right to the | |||||||||||||||||||||
allocation of a capital or debt security; | |||||||||||||||||||||
setting specific ceilings for capital | |||||||||||||||||||||
increases likely to result from the | |||||||||||||||||||||
allocation of free shares | |||||||||||||||||||||
This press release is available at www.kaufmanbroad.fr | |||||||||||||||||||||
Contacts | |||||||||||||||||||||
Chief Financial Officer | Press Relations | ||||||||||||||||||||
Bruno Coche | DGM Conseil | ||||||||||||||||||||
+33 (0)1 41 43 44 73 | Thomas Roborel de Climens - +33 (0)6 14 50 15 84 | ||||||||||||||||||||
Infos-invest@ketb.com | thomasdeclimens@dgm-conseil.fr |
Kaufman & Broad: Emmeline Cacitti
+33 (0)6 72 42 66 24 / ecacitti@ketb.com
About Kaufman & Broad - Kaufman & Broad has been designing, developing, building, and selling single-family homes in communities, apartments, and offices on behalf of third parties for more than 50 years. Kaufman & Broad is one of the leading French developers-builders due to the combination of its size and profitability, and the strength of its brand.
The Kaufman & Broad Registration Document was filed with the French Financial Markets Authority ("AMF") under No. 21-0239 on March 31, 2021. It is available on the AMF (www.amf-france.org)and Kaufman & Broad (www.kaufmanbroad.fr) websites. It contains a detailed description of Kaufman & Broad's business activities, results, and outlook, as well as the associated risk factors. Kaufman & Broad specifically draws attention to the risk factors set out in Chapter 4 of the Registration Document. The occurrence of one or more of these risks might have a material adverse impact on the Kaufman & Broad.
5/5
COMBINED ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING
MAY 6, 2021
Attachments
- Original document
- Permalink
Disclaimer
Kaufman et Broad SA published this content on 20 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 May 2021 14:47:05 UTC.